Canada markets open in 2 hours 24 minutes

Defence Therapeutics Inc. (DTC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
1.1900-0.0300 (-2.46%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 54.07M
Enterprise Value 55.23M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)89.80
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -7.86

Trading Information

Stock Price History

Beta (5Y Monthly) 1.40
52-Week Change 3-60.20%
S&P500 52-Week Change 323.57%
52 Week High 33.3000
52 Week Low 30.0000
50-Day Moving Average 31.6392
200-Day Moving Average 32.3038

Share Statistics

Avg Vol (3 month) 324.14k
Avg Vol (10 day) 346.34k
Shares Outstanding 545.44M
Implied Shares Outstanding 645.44M
Float 842.55M
% Held by Insiders 14.72%
% Held by Institutions 10.00%
Shares Short (Mar 15, 2024) 4545
Short Ratio (Mar 15, 2024) 40.02
Short % of Float (Mar 15, 2024) 4N/A
Short % of Shares Outstanding (Mar 15, 2024) 40.00%
Shares Short (prior month Feb 15, 2024) 42.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-1,496.29%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.34M
Net Income Avi to Common (ttm)-13.59M
Diluted EPS (ttm)-0.1900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)351k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1.51M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.18
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-6.77M
Levered Free Cash Flow (ttm)-2.03M